The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
bipartisan interest grows in reforming medicare advantage and health equity initiatives
The potential for reform in Medicare Advantage (MA) is gaining bipartisan interest, with discussions around quality bonus payments, risk adjustment, and the Health Equity Index (HEI). While the Trump administration may favor MA expansion, concerns about health equity and budget cuts loom, creating uncertainty about future policies. The political landscape suggests a complex interplay between healthcare priorities and fiscal conservatism, leaving stakeholders wary of potential disruptions.
elevance health challenges star ratings methodology claiming 375 million dollar loss
Elevance Health is suing the federal government over its star ratings, claiming that a flawed methodology led to a significant financial penalty of $375 million. The insurer argues that minor scoring variances unfairly impact its ratings, which are crucial for securing quality bonus payments and improving member benefits. Additionally, the lawsuit highlights issues with hidden data affecting other contracts, further complicating the evaluation process.
health plans adjust coverage amid lawsuits and new legislative measures
New York City has ended coverage for GLP-1 weight-loss drugs, citing an error in their inclusion, while continuing to cover them for diabetes. Meanwhile, Michigan has filed a lawsuit against PBMs Optum Rx and Express Scripts for alleged collusion with opioid manufacturers, seeking accountability for their role in the opioid crisis. Additionally, health plans are previewing their Medicare Advantage offerings for 2025, with various expansions and new benefits aimed at diverse populations.
medicare advantage plans face scrutiny over inflated home visit payments
Medicare Advantage plans received $7.5 billion in risk-adjusted payments, raising concerns over potential upcoding by major insurers like UnitedHealth Group and Humana. A federal report revealed that $4.2 billion stemmed from at-home visits, which accounted for only 13% of chart reviews in 2022, with many diagnoses lacking follow-up care. The report urged stricter oversight from CMS, highlighting that 75% of payments were linked to just 13 conditions, primarily identified through at-home assessments.
centene files lawsuit against cms over 2025 star ratings controversy
Centene has filed a lawsuit against the Centers for Medicare & Medicaid Services (CMS) over the 2025 star ratings, claiming that a miscategorized secret shopper call unfairly impacted their scores. The insurer argues that the call failure was due to CMS's software, not their service, and estimates a $73 million revenue loss from the rating drop. This legal action follows similar lawsuits from other insurers like UnitedHealth and Humana, highlighting ongoing disputes over the fairness of CMS's scoring system.
humana files lawsuit against cms over controversial star ratings for 2025
Humana is suing the Centers for Medicare & Medicaid Services (CMS) over its 2025 star ratings, claiming the agency's actions violate the Administrative Procedure Act and that it failed to disclose recalculation criteria. The lawsuit highlights issues with the scoring of customer service calls, which Humana argues were unfairly penalized due to external factors. With a significant drop in members in high-rated plans, the outcome could have major financial implications for the insurer.
humana files lawsuit against cms over 2025 medicare advantage star ratings
Humana has filed a lawsuit against the Centers for Medicare and Medicaid Services (CMS) over the 2025 Medicare Advantage and Part D Star Ratings, claiming the agency did not adhere to its own rules and failed to provide necessary data. The complaint highlights significant changes in cut points that drastically reduced Humana's star ratings, impacting the quality bonus payments essential for lowering costs or enhancing benefits for enrollees. Humana seeks the retraction and recalculation of the ratings, emphasizing the critical importance of these ratings in the half-trillion-dollar Medicare program.
elevance health explores options after decline in medicare advantage star ratings
Elevance Health's CEO, Gail Boudreaux, announced the company is exploring options following a decline in its Medicare Advantage Star Ratings for 2025, which affects member enrollment in higher-rated plans. Despite improvements in nearly 60% of measures for 2026, a narrow miss on a key contract led to significant rating impacts. The situation reflects broader industry challenges, with other insurers like UnitedHealthcare and Humana also contesting their ratings amid increased cut points.
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.